Prioritization and timing of outcomes and endpoints after aneurysmal subarachnoid hemorrhage in clinical trials and observational studies: proposal of a …
MN Stienen, JM Visser-Meily, TA Schweizer, D Hänggi… - Neurocritical care, 2019 - Springer
Introduction In studies on aneurysmal subarachnoid hemorrhage (SAH), substantial
variability exists in the use and timing of outcomes and endpoints, which complicates …
variability exists in the use and timing of outcomes and endpoints, which complicates …
Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a …
MN Stienen, JM Visser-Meily, TA Schweizer… - Neurocritical …, 2019 - search.proquest.com
Methods This article summarizes the recommendations of the UIA and SAH CDE Outcomes
and Endpoints subgroup, which consisted of an international and multidisciplinary ad hoc …
and Endpoints subgroup, which consisted of an international and multidisciplinary ad hoc …
[PDF][PDF] Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a …
MN Stienen, JM Visser‑Meily, TA Schweizer, D Hänggi… - Neurocrit Care, 2019 - aneux.ch
Introduction: In studies on aneurysmal subarachnoid hemorrhage (SAH), substantial
variability exists in the use and timing of outcomes and endpoints, which complicates …
variability exists in the use and timing of outcomes and endpoints, which complicates …
Prioritization and Timing of Outcomes & Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies
researchgate.net
Aim: In studies on aneurysmal subarachnoid hemorrhage (SAH), substantial variability
exists in the use and timing of outcomes and endpoints, which complicates interpretation …
exists in the use and timing of outcomes and endpoints, which complicates interpretation …
Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a …
MN Stienen, JM Visser-Meily, TA Schweizer… - Neurocritical …, 2019 - repub.eur.nl
Introduction: In studies on aneurysmal subarachnoid hemorrhage (SAH), substantial
variability exists in the use and timing of outcomes and endpoints, which complicates …
variability exists in the use and timing of outcomes and endpoints, which complicates …
Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a …
MN Stienen, JM Visser-Meily, TA Schweizer… - Neurocritical …, 2019 - europepmc.org
Methods This article summarizes the recommendations of the UIA and SAH CDE Outcomes
and Endpoints subgroup, which consisted of an international and multidisciplinary ad hoc …
and Endpoints subgroup, which consisted of an international and multidisciplinary ad hoc …
[引用][C] Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a …
MN Stienen, JM Visser-Meily… - Neurocritical …, 2019 - researchportal.helsinki.fi
Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid
Hemorrhage in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary …
Hemorrhage in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary …
Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a …
MN Stienen, JM Visser-Meily, TA Schweizer… - Neurocritical …, 2019 - iro.uiowa.edu
In studies on aneurysmal subarachnoid hemorrhage (SAH), substantial variability exists in
the use and timing of outcomes and endpoints, which complicates interpretation and …
the use and timing of outcomes and endpoints, which complicates interpretation and …
[PDF][PDF] Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a …
MN Stienen, JM Visser‑Meily, TA Schweizer, D Hänggi… - Neurocrit Care, 2019 - aneux.ch
Introduction: In studies on aneurysmal subarachnoid hemorrhage (SAH), substantial
variability exists in the use and timing of outcomes and endpoints, which complicates …
variability exists in the use and timing of outcomes and endpoints, which complicates …
Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a …
MN Stienen, JM Visser-Meily… - Neurocrit …, 2019 - academicworks.medicine.hofstra …
Abstract© 2019, Neurocritical Care Society. Introduction: In studies on aneurysmal
subarachnoid hemorrhage (SAH), substantial variability exists in the use and timing of …
subarachnoid hemorrhage (SAH), substantial variability exists in the use and timing of …